Scarica l'app Stockscreener
27.25
2.14%
0.57
Dopo l'orario di chiusura:
27.40
0.15
+0.55%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$26.68
Aprire:
$26.87
Volume 24 ore:
870.41K
Relative Volume:
0.56
Capitalizzazione di mercato:
$1.34B
Reddito:
$224.45M
Utile/perdita netta:
$-95.27M
Rapporto P/E:
-14.12
EPS:
-1.93
Flusso di cassa netto:
$-43.74M
1 W Prestazione:
+1.57%
1M Prestazione:
-1.62%
6M Prestazione:
+62.30%
1 anno Prestazione:
-13.79%
Intervallo 1D:
$26.69
$27.33
Intervallo di 1 settimana:
$25.97
$27.33
Portata 52W:
$13.50
$33.28
Staar Surgical Co Stock (STAA) Company Profile
Nome
Staar Surgical Co
Settore
Industria
Telefono
(626) 303-7902
Indirizzo
1911 WALKER AVE, MONROVIA, CA
Confronta STAA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
STAA
Staar Surgical Co
|
27.25 | 1.32B | 224.45M | -95.27M | -43.74M | -1.93 |
|
ISRG
Intuitive Surgical Inc
|
435.73 | 154.00B | 9.15B | 2.63B | 1.99B | 7.1661 |
|
BDX
Becton Dickinson Co
|
186.66 | 53.47B | 21.39B | 1.61B | 2.55B | 5.5609 |
|
RMD
Resmed Inc
|
273.01 | 39.70B | 5.15B | 1.40B | 1.65B | 9.5082 |
|
ALC
Alcon Inc
|
72.60 | 35.62B | 10.03B | 1.07B | 1.39B | 2.1549 |
|
WST
West Pharmaceutical Services Inc
|
262.47 | 18.82B | 2.96B | 487.70M | 344.00M | 6.6758 |
Staar Surgical Co Stock (STAA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-21 | Iniziato | Wells Fargo | Equal Weight |
| 2025-02-12 | Downgrade | BTIG Research | Buy → Neutral |
| 2025-02-12 | Downgrade | Jefferies | Buy → Hold |
| 2025-02-12 | Downgrade | Mizuho | Outperform → Neutral |
| 2025-02-12 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2024-07-15 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2024-06-11 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2024-03-11 | Aggiornamento | Stifel | Hold → Buy |
| 2023-12-05 | Downgrade | Needham | Buy → Hold |
| 2023-12-04 | Iniziato | Morgan Stanley | Equal-Weight |
| 2023-09-15 | Downgrade | The Benchmark Company | Buy → Hold |
| 2023-08-03 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2023-06-07 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2023-04-17 | Iniziato | Piper Sandler | Neutral |
| 2023-02-06 | Downgrade | BTIG Research | Buy → Neutral |
| 2022-12-28 | Reiterato | BTIG Research | Buy |
| 2022-12-08 | Iniziato | Stifel | Hold |
| 2022-11-07 | Aggiornamento | Sidoti | Neutral → Buy |
| 2022-10-14 | Ripresa | Stephens | Overweight |
| 2022-10-13 | Iniziato | Mizuho | Buy |
| 2022-04-08 | Iniziato | Needham | Buy |
| 2022-03-28 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2022-03-18 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2021-07-09 | Iniziato | Oppenheimer | Perform |
| 2021-01-19 | Downgrade | The Benchmark Company | Buy → Hold |
| 2020-10-26 | Downgrade | Sidoti | Buy → Neutral |
| 2020-08-31 | Aggiornamento | Sidoti | Neutral → Buy |
| 2020-08-06 | Reiterato | The Benchmark Company | Buy |
| 2020-07-06 | Downgrade | Sidoti | Buy → Neutral |
| 2020-06-24 | Downgrade | BTIG Research | Buy → Neutral |
| 2020-06-15 | Iniziato | Jefferies | Buy |
| 2019-12-04 | Iniziato | BTIG Research | Buy |
| 2018-09-24 | Reiterato | The Benchmark Company | Buy |
| 2018-08-06 | Ripresa | The Benchmark Company | Buy |
| 2017-11-20 | Reiterato | The Benchmark Company | Buy |
| 2017-08-14 | Reiterato | The Benchmark Company | Buy |
| 2017-03-03 | Reiterato | The Benchmark Company | Buy |
| 2016-05-18 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2013-09-10 | Ripresa | The Benchmark Company | Buy |
| 2013-02-28 | Reiterato | The Benchmark Company | Buy |
| 2012-11-01 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2012-03-02 | Iniziato | Northland Securities | Outperform |
| 2011-10-25 | Reiterato | The Benchmark Company | Buy |
| 2010-10-12 | Iniziato | Morgan Joseph | Buy |
| 2010-05-11 | Iniziato | Benchmark | Buy |
Mostra tutto
Staar Surgical Co Borsa (STAA) Ultime notizie
Large Staar Holders Oppose $1.5B Sale - Orange County Business Journal
Broadwood slams STAAR board over “carelessness” in Alcon sale defense By Investing.com - Investing.com Canada
SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates STAA, GES, SMLR on Behalf of Shareholders - GlobeNewswire Inc.
Investor Group Opposes Alcon's Acquisition of STAAR Surgical (AL - GuruFocus
Broadwood issues letter to Staar Surgical board questioning ‘rush’ in Alcon sale - TipRanks
Broadwood Partners Issues Letter to STAAR Surgical’s Board Questioning Its Diligence in Rush to Reaffirm Support for Alcon Sale - MarketScreener
Will STAAR Surgical Company benefit from macro trendsWeekly Trend Summary & Stock Portfolio Risk Management - newser.com
STAAR Surgical holders should vote against sale to Alcon, Glass Lewis says - MSN
Global Myopia Treatment Devices Market Poised for Strong Growth at a CAGR of ~8% by 2032, Driven by Technological Innovations and Increasing Eye Care Demand | DelveInsight - GlobeNewswire
Glass Lewis recommends against STAAR–Alcon merger, bolstering Broadwood’s campaign - Investing.com
Live market analysis of STAAR Surgical CompanyMarket Movers & Real-Time Chart Breakout Alerts - newser.com
STAAR Surgical (STAA): A Fresh Look at Valuation Following Recent Share Price Cooldown - simplywall.st
Glass Lewis Issues Recommendations to Shareholders of STAAR Surgical Company - MarketScreener
STAAR Surgical Board Defends $1.5 Billion Alcon Acquisition Plan - Finimize
AI Insurance Is Expensive - Bloomberg.com
Alcon (ALC) Faces Opposition in Staar Surgical Merger Deal - GuruFocus
STAAR urges shareholders to approve Alcon merger despite Glass Lewis report - Investing.com India
STAAR Surgical (STAA): Proxy Adviser Urges Rejection of Alcon De - GuruFocus
Glass Lewis Advises Against Alcon (ALC) Acquisition of STAAR - GuruFocus
STAAR Surgical Provides Information to Shareholders - MarketScreener
Broadwood Partners: Leading Advisory Firm Glass Lewis Urges STAAR Shareholders to Vote “AGAINST” Sale to Alcon - MarketScreener
Defender Capital Opposes STAAR Surgical's Proposed Acquisition By Alcon - Nasdaq
Defender Capital Opposes STAAR Surgical's Proposed Sale to Alcon - Stock Titan
STAAR Surgical’s Long-Term Shareholder Says Proposed Deal With Alcon Undervalues The Company - Stocktwits
STAAR shareholders urged to vote for Alcon merger with 59% premium - Investing.com Canada
Yunqi Capital opposes sale of STAAR Surgical to Alcon - Investing.com
Yunqi Capital opposes sale of STAAR Surgical to Alcon By Investing.com - Investing.com Nigeria
Yunqi Capital, One of STAAR Surgical Company’s Largest Shareholders, Reiterates Its Opposition to the Proposed Merger with Alcon - The Joplin Globe
$62/Share Offer Challenged: STAAR Shareholder Yunqi (5.1%) Reiterates Opposition Ahead of Vote - Stock Titan
STAAR Surgical Faces Shareholder Clash Over Alcon Buyout - Finimize
Broadwood urges STAAR shareholders to reject $28 per share Alcon deal - Investing.com
Broadwood urges shareholders to vote against proposed acquisition of STAAR by Alcon - MarketScreener
Broadwood Partners Issues Letter to STAAR Surgical’s Board Questioning Its Judgment in Proposed Sale to Alcon - Stock Titan
STAAR Surgical Addresses Broadwood Partners’ Flawed, Misleading, and Misinformed Claims - MarketScreener
STAAR Surgical: Independent Industry Analysts Recognize Merits of Alcon Merger, the Value It Provides, and the Downside Risks Facing STAAR on Standalone Basis - Business Wire
59% premium to 90-day VWAP: STAAR Surgical backs $28 Alcon merger and urges stockholders to vote - Stock Titan
Major STAAR Surgical Investors Push Back On Alcon Acquisition - Finimize
STAAR Surgical (STAA): Evaluating Valuation Following Recent Share Price Surge - Yahoo
Johnson Fistel Investigates Fairness of Proposed Sale of STAAR Surgical - GlobeNewswire
Why STAAR Surgical Company stock could rally in 2025Earnings Recap Summary & Daily Entry Point Alerts - newser.com
27.5% Holder Broadwood Releases 81-Page Brief Urging STAAR Surgical Vote Against Alcon Deal - Stock Titan
How hedge fund analytics apply to STAAR Surgical Company stockWeekly Market Report & Safe Capital Preservation Plans - newser.com
Comparing STAAR Surgical Company in custom built stock radarsTrade Performance Summary & Comprehensive Market Scan Reports - newser.com
BUYOUT INVESTIGATION: Does $28.00 Per Share Buyout Offer Shortchange STAAR Surgical Company (NASDAQ: STAA) Shareholders? Kaskela Law LLC is Investigating the Buyout Offer and Encourages STAA Shareholders to Contact the Firm - PR Newswire
Combining price and volume data for STAAR Surgical CompanyTrade Analysis Report & Community Consensus Trade Alerts - newser.com
Alcon, STAAR Surgical see US antitrust waiting period expire - MLex
Alcon and STAAR Surgical Announce Expiration of Hart-Scott-Rodino Waiting Period for Alcon’s Acquisition of STAAR - MarketScreener
$1.5B Eye Care Merger Progresses: Alcon's Premium Buyout of STAAR Surgical Clears Key Regulatory Hurdle - Stock Titan
Broadwood files definitive proxy, STAAR reaffirms Alcon merger - Investing.com
Broadwood files definitive proxy, STAAR reaffirms Alcon merger By Investing.com - Investing.com UK
Alcon: Seeing Is Believing As Buyout Of STAAR Surgical Hangs In Balance (NYSE:ALC) - Seeking Alpha
Staar Surgical Co Azioni (STAA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.84%
3.32%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):